Abstract:Amenorrhea is the absence of menstrual bleeding.There are two types of amenorrhea, primary and secondary. Although amenorrhea may result from a number of different conditions, a systematic evaluation including a detailed history, physical examination, and laboratory assessment of selected serum hormone levels can usually identify the underlying cause. Treatment goals for patients with amenorrhea may vary considerably, and depend on the patient and the specific diagnosis.The objective of the presentation is to describe the guidelines for the diagnosis and treatment of different types of amenorrhea and relate the major recommendations for the patient management. Congenital malformations of the female genital tract are common miscellaneous deviations from normal anatomy with amenorrhea and reproductive consequences. Until now, three systems have been proposed for their categorization but all of them are associated with serious limitations. The ESHRE/ESGE classification system of female genital anomalies (2013) is based on anatomy. Turner syndrome is usually accompanied by hypergonadotropic hypogonadism and primary or secondary amenorrhea due to gonadal dysgenesis.European Society of Endocrinology Clinical practice guidelines 2017 recommend that estrogen replacement should start between 11 and 12 years of age increasing to adult dosing over 2–3 years (moderate recommendation), and adding progesterone once breakthrough bleeding occurs or after 2 years of estrogen treatment (strong recommendation). Functionalhypothalamic amenorrhea (FHA) is a form of chronic anovulation, not due to identifiable organic causes, butoften associated with stress, weight loss, excessive exercise, or a combination thereof. Investigationsshould include assessment of systemic and endocrinologic etiologies, as FHA is a diagnosis of exclusion. Diagnostic options of FHA include physical examination, progestin challenge test, abdominal or transvaginal ultrasound, and/or MRI, depending on the context and patient preferences. In adolescents and women with FHA, an EndocrineSociety Clinical Practice Guideline 2017 recommend correcting the energy imbalance to improve hypothalamic–pituitary–ovarian axis function, psychological support, and short-term use of transdermal E2 therapy with cyclic oral progestin (not oral contraceptives or ethinyl E2) in adolescents and women who have nothad return of menses after a reasonable trial of nutritional, psychological, and/or modified exercise intervention. Premature ovarian insufficiency is a clinical syndrome defined by loss of ovarian activity before the age of 40. POI is characterised by menstrual disturbance (amenorrhea or oligomenorrhea) with raised gonadotropins and low estradiol. Guideline of the European Society of Human Reproduction and Embryology 2015 recommends the following diagnostic criteria: oligo/amenorrhea for at least 4 months, and an elevated FSH level > 25 IU/l on two occasions > 4 weeks apart. Untreated POI is associated with reduced life expectancy, largely due to cardiovascular disease. Women with POI should be informed that there is a small chance of spontaneous pregnancy (GPP). Oocyte donation is an established option for fertility in women with POI. Spontaneous pregnancies after idiopathic POI or most forms of chemotherapy do not show any higher obstetric or neonatal risk than in the general population. Hormone replacement therapy is indicated for the treatment of symptoms of low estrogen and to reduce futurerisk of cardiovascular disease, cognitive impairment, reduced bone mineral density in women with POI. Hormone replacement therapy with early initiation is strongly recommended in women with POI to control future risk of cardiovascular disease; it should be continued at least until the average age of natural menopause.

Primary amenorrhoea - cytogenetic study in 40 Indian women

Analysis of chromosomal karyotypes in 1068 cases of genetic counseling

Frequency, clinical presentation and management of primary amenorrhea in a tertiary care setting

Girls referred for amenorrhea: analysis of a patient series from a specialist center

Association of Abnormal Cytology and risk factors in Women of Assam, India

Cytogenetic Analysis of 531 Chinese Women with Premature Ovarian Failure.

Amenorrhea: A Systematic Approach to Diagnosis and Management

Cytogenetic abnormalities associated with reproductive failure in Pakistani population: experience of a tertiary care hospital

Cytogenetic profile of patients with clinical spectrum of ambiguous genitalia, amenorrhea, and Turner phenotype: A 21-year single-center experience

Evaluation of Hormonal Profile and Ovarian Morphology among Adolescent Girls with Menstrual Irregularities in a Tertiary Care Centre at Central India

CAUSES OF VISITING ADOLESCENT GIRLS IN GYNAECOLOGY OPD AND THEIR AWARENESS OF REPRODUCTIVE HEALTH PROBLEMS

The Role of Hormonal Imbalances in Amenorrhea

[Preliminary Study of Chromosome Aberrations in Pituitary Adenoma].

Awareness regarding knowledge associated with polycystic ovarian syndrome (PCOS) among women in Wardha district- A cross-sectional study.

Evaluating Underlying Endocrine Abnormalities in Adolescents with Menstrual Disorders Presenting at a Tertiary Care Hospital

Congenital Adrenal Hyperplasia - A Comprehensive Review of Genetic Studies on 21-Hydroxylase Deficiency from India

Amenorrhea: Guidelines and practice

Exome Sequencing to Identify Novel Variants Associated with Secondary Amenorrhea and Premature Ovarian Insufficiency (POI) in Saudi Women

Early surgical menopause and its correlates: A case series from a tertiary healthcare institute in a tribal area of Jharkhand, India

Diverse genetic causes of amenorrhea in an ethnically homogeneous cohort and an evolving approach to diagnosis

Background, Diagnosis, Types, Management/Prevention and Implications of Chromosomal Abnormalities